Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (10): 1099-1105.doi: 10.12092/j.issn.1009-2501.2022.10.003

Previous Articles     Next Articles

Dioscin attenuates inflammatory injury in uric acid-induced renal tubular epithelial cells by suppression of NF-κB signaling pathway

LIU Peng, WANG Chen, WANG Yun, QIU Xinping   

  1. Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, China
  • Received:2022-06-06 Revised:2022-10-14 Online:2022-10-27 Published:2022-11-14

Abstract: AIM: To observe the effect of Dioscin treatment on NF-κB signaling pathway and cellular inflammatory injury and explore its potential mechanism in uric acid-induced mouse tubular epithelial cells (mTECs).  METHODS: After 1.2 mol/L uric acid induced mTECs, Dioscin and NF-κB P65 inhibitor BAY11-7082 were given to intervene respectively. IκB-α, NF-κB P65, PP65, NLRP3, IL-1β and β-actin were detected by Western Blot, immunofluorescence staining and real-time PCR. RESULTS: Western Blot, immunofluorescence staining and real-time PCR analysis showed that expression levels of PP65, NLRP3 and IL-1β were significantly downregulated in the uric acid-induced mTECs with Dioscin and BAY11-7082 treatment. CONCLUSION: Dioscin attenuates uric acid-induced cellular inflammatory damage by suppression NF-κB signaling pathway. 

Key words: Dioscin, hyperuricemic nephropathy, NF-κB signaling pathway, inflammatory response, NF-κB P65 inhibitor BAY11-7082

CLC Number: